3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lymphoma, Large B-Cell, Diffuse
6
Lymphoma, Follicular
4
Lymphoma
4
Hodgkin Disease
4
Prostatic Neoplasms
3
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
3
Lymphoma, Mantle-Cell
3
Lymphoma, Large-Cell, Immunoblastic
3
Lymphoma, Large-Cell, Anaplastic
3
Lymphoma, Extranodal NK-T-Cell
3
Lymphoma, B-Cell, Marginal Zone
3
Leukemia, Lymphocytic, Chronic, B-Cell
3
Congenital Abnormalities
3
Burkitt Lymphoma
3
Waldenstrom Macroglobulinemia
2
Sezary Syndrome
2
Rectal Neoplasms
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Myeloproliferative Disorders
2
Myelodysplastic Syndromes
2
Mycosis Fungoides
2
Multiple Myeloma
2
Lymphoma, T-Cell, Peripheral
2
Lymphoma, T-Cell, Cutaneous
2
Lymphoma, Non-Hodgkin
2
Leukemia, Myeloid, Acute
2
Leukemia, Myeloid, Accelerated Phase
2
Immunoblastic Lymphadenopathy
2
Colorectal Neoplasms
2
Colonic Neoplasms
2
Interventions
Magnetic Resonance Spectroscopy
2
Everolimus
2
Erlotinib Hydrochloride
2
ribociclib
1
palbociclib
1
olaparib
1
etoposide phosphate
1
erdafitinib
1
X-Rays
1
Sunitinib
1
Specimen Handling
1
Radiotherapy
1
Phantoms, Imaging
1
Nuclear Medicine Department, Hospital
1
N-(3-chloro-4-((3-fluorobenzyl)oxy)phenyl-6-(5-((methylsulfonyl)ethyl)aminomethyl)-2-furyl)-4-quinazolinamine
1
Microarray Analysis
1
Lapatinib
1
Irinotecan
1
Immunologic Techniques
1
Immunohistochemistry
1
Immunoglobulin G
1
Ifosfamide
1
Fluorodeoxyglucose F18
1
Etoposide
1
Donepezil
1
Disulfides
1
Dasatinib
1
Cyproheptadine
1
Carboplatin
1
Blotting, Western
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Familial ependymoma
×
Amplified Fragment Length Polymorphism Analysis
×
Clear all
No trials found.